Crossmark

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.06.028

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Golpe, Rafael

Pérez-de-Llano, Luis A.

Dacal, David

Guerrero-Sande, Hector

Pombo-Vide, Beatriz

Ventura-Valcárcel, Pablo
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.06.028

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.06.013

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.